| | |
Non treated cats (n=6)
|
Treated cats (n=6)
|
|---|
|
FIO2 (%)
| |
21
|
8
|
100
|
21
|
8
|
100
|
|---|
|
Baseline
|
CSND
|
3.4 ± 0.5
|
35.5 ± 5.9
|
0.5 ± 0.1
|
4.2 ± 1.0
|
30.2 ± 4.1
|
0.5 ± 0.1
|
| |
ABP
|
123.6 ± 6.8
|
99.7 ± 13.9
|
115.5 ± 7.5
|
99.9 ± 6.9*
|
72.0 ± 13.0
|
117.8 ± 7.4
|
|
DA
|
CSND
|
2.5 ± 0.6
|
38.9 ± 7.6
|
0.4 ± 0.1
|
0.7 ± 0.4 +*
|
28.8 ± 6.3
|
0.1 ± 0.01 +*
|
| |
ABP
|
106.2 ± 7.5
|
85.3 ± 8.2
|
113.2 ± 7.1
|
93.6 ± 5.9
|
62.2 ± 12.3
|
130.6 ± 9.6
|
|
DA+ACh
|
CSND
|
4.1 ± 0.6$
|
39.1 ±7.1
|
0.5 ±0.2
|
2.4 ±1.1$
|
35.9 ± 6.3
|
0.4 ± 0.05$
|
| |
ABP
|
92.3 ± 6.0+
|
84.3 ± 18.0
|
98.1 ± 5.3
|
57.3 ± 9.5+*$
|
47.9 ± 9.6
|
83.2 ±13.7
|
- +P < 0.01 vs baseline; *
P < 0.04 vs non-treated; $
P < 0.04 vs DA.
